FDA Inspection 1197609 — Saumya Sharma, MD

Saumya Sharma, MD — FEI 3013846043

The FDA completed an inspection of Saumya Sharma, MD on Feb 3, 2023 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 3, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.